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AN ULTRASTRUCTURAL ANALYSIS OF MICROGLIAL MORPHOLOGICAL 
CHANGES IN RESPONSE TO MANIPULATION OF RNA BINDING PROTEIN 
TIA1 IN THE P301S MOUSE MODEL OF ALZHEIMER’S DISEASE  
 
NICHOLAS W. NICOLETTI 
ABSTRACT 
 Microglia are essential to the brain’s innate immune response and play a vital role 
in neuropathology related to tauopathies. Understanding how microglia change in 
response to differential expression of RNA binding protein T-cell intracellular antigen 1 
(TIA1) will lend insight to microglial function in tauopathy. In preliminary studies our 
laboratory has shown that decreasing the expression of TIA1 has an inverse and dose 
dependent effect on activated microglial density in the dentate gyrus of the P301S mouse 
(PhD Candidate Chelsey LeBlang, 2018). Here, we utilized serial sectioning electron 
microscopy to define whether this relationship between TIA1 level and microglia remains 
consistent in the hilus and granule cell layer (GCL) of the dentate gyrus. Our analyses of 
microglial volume and microglial interactions within the neuropil have yielded four 
conclusions. First, the hilus, but not the GCL, exhibited a significant decrease in 
microglial volume per volume of tissue with the knock out and heterozygous expression 
of TIA1. Second, the number of appositions on microglia steadily increased on AT8+ and 
AT8- presynaptic and postsynaptic appositions in the hilus with decreasing TIA1 
expression. Third, with the exception of one AT8- somatic apposition, the surface area of 
microglia apposing AT8+ somata is greater than any other structure and exhibits a dose 
dependent decrease with decreasing TIA1 expression. Fourth, in the GCL there is a larger 
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fractional surface area of AT8- presynaptic and AT8+ postsynaptic structures when 
compared to their respective synaptic counterparts. Though not entirely consistent with 
previous data, this study has important implications for microglial function in tauopathy 
and related diseases.  
		 viii 
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INTRODUCTION 
Since its identification by Martin Lewis Perl over forty years ago (Tikkanen, 
Encyclopedia Britannica, 2018) tau has become a hallmark of many neurodegenerative 
diseases such Alzheimer’s disease (AD) and frontotemporal dementia. The tau protein is 
a microtubule associate protein which, under physiological conditions, serves to maintain 
normal functioning within the neuron by facilitating the assembly and stabilization of 
microtubules as well as promoting neurite outgrowth (Iqbal et al. 2005, Kadavath et al. 
2015). Tau’s function when bound to microtubules is highly dynamic. Smaller, more 
evolutionarily conserved groups of residues that comprise tau are dedicated to binding 
tightly to axonal microtubules while other portions remain quite flexible and are 
important for protein aggregation and interaction with microtubules (Kadavath et al. 
2015). Tau exhibits an internal competition between homeostatic microtubule interaction 
and pathological misfolding, making it susceptible to stress. Under acute stress, such as 
anesthesia, tau reversibly and temporarily hyperphosphorylates (Iqbal et al. 2010). 
However, when tau is abnormally hyperphosphorylated, such as in AD, pathological 
misfolding occurs. It has been found that this misfolding is preceded by microglial 
activation and is followed by a dramatic increase in the formation of neurofibrillary 
tangles (NFT) comprised of a beta sheet configuration of tau. Furthermore, tau’s 
interaction with stress granules is altered and the healthy stress response of the neuron is 
altered (Ash et al. 2014, Iqbal et al. 2005). Neurofibrillary tangles are abnormal 
accumulations of hyperphosphorylated tau. Soluble and oligomeric configurations 
preceding NFT formation contribute to decreased transport across the neuron and 
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overtime lead to neuronal degeneration (Ghetti et al., 2015, Rocher et al., 2010). It is for 
this reason that soluble and oligomeric tau are considered a toxic species.  
Microgliosis is the activation of microglia in response to pathological injury, 
typically seen in events of neuroinflammation and more recently seen prior to NFT 
formation (Li et al. 2016, Yoshiyama et al. 2007). Stress granules are insoluble protein 
aggregates which accumulate in response to stress and have been found to be 
significantly larger in diseases associated with pathological tau (Ash et al. 2014). The 
relationship between pathological tau, microgliosis and stress granules is important, and 
of specific interest in the primary target region of Alzheimer’s disease, the hippocampus. 
It is this relationship that will be evaluated and analyzed in this thesis.  
 
Tau Pathology 
Frontotemporal Dementia with Parkinsonism linked to chromosome 17 (FTDP-
17) is one of the many neurodegenerative diseases characterized by tau pathology. The 
gene linked to pathological tau is found on chromosome 17 in FTDP-17. This gene is 
targeted in a common animal model of tau pathology, the P301S transgenic mouse. Due 
to the rapid, early-onset expression of FTDP-17 occurring within these models, the 
P301S transgenic mouse is an ideal subject to study tauopathy (Yoshiyama et al. 2007). 
There are apparent and dramatic differences between the WT mouse and the P301S 
transgenic mouse (Figure 1). The P301S mouse exhibits major dorsal hippocampal 
degeneration as well as significant enlargement of both lateral ventricles and the third 
ventricle. This degeneration in the medial temporal lobe and ventricular enlargement is 
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phenotypically similar to patients with advanced FTDP-17 as well as AD. Furthermore, 
pathologic tau expression, and therefore neurodegeneration, in the P301S model increases 
with age. NFT formation, as a result of hyperphosphorylated tau, tends to occur sometime 
after 3 months of age. With the naked eye, one can see the progression of this 
deterioration targeted at the medial temporal lobe as well as an increase of ventricle size 
over time. When pathologic tau is present, it is common for the diseased tissue to 
manifest in this way. However, there is more to consider in tau pathology than tau itself. 
 
WT P301S TIA1+/+ 
P301S TIA1+/- P301S TIA1 -/- 
Figure 1. Tissue of 9mo Mice from each Genotype. (Chelsey LeBlang) Clear increase 
in ventricular enlargement and degeneration of the dorsal hippocampus with decreased 
expression of TIA1.  
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Stress Granules and RNA Binding Proteins  
 The P301S model has been used to assess tau’s relationship to RNA binding 
proteins and stress granules in a number of recent studies. Stress granules are cytoplasmic 
RNA granules which transform in response to stress. There is a high density of RNA 
granules in the neuron which properly regulate and transport mRNA within the cell 
(Appico et al. 2017). These granules are able to sequester mRNAs in the cell and 
facilitate their metabolism, activation, and storage following stress (Vanderweyde et al. 
2016). During an insult, the abundant population of RNA granules transform into stress 
granules. In a recent study using the P301S transgenic mouse, investigators manipulated a 
specific RNA binding protein which serves as a core nucleating factor for these stress 
granules: T-cell intracellular antigen 1 or TIA1. Decreasing, but not knocking out, the 
expression of TIA1 proved to protect against neurodegeneration and behavioral deficits 
(Apicco et al. 2017). There is a strong, almost codependent, interaction between tau and 
RNA binding proteins, specifically between tau and TIA1. Normally, TIA1 interacts with 
proteins in RNA metabolism under the regulation of tau. Due to tau’s involvement in this 
process, however, any changes to tau itself will directly affect proper functioning of TIA1 
and therefore RNA granules. It has been shown that the presence of pathologic tau 
increases the rate of stress granule formation (Vanderweyde et al. 2016). This indicates 
that the normal interactions occurring between TIA1 and RNA granules have been 
disrupted. There is compelling evidence linking TIA1 to the progression of tau pathology  
that suggests a key series of molecular events between the two which, in turn can 
exacerbate neurodegenerative disease (Figure 2). While considering this relationship, it is 
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important to concordantly consider how tau pathology is related to neuroinflammation, 
another hallmark of neurodegeneration. There are many markers of neuroinflammation 
and neurodegeneration such as activated astrocytes, Lewy bodies in Parkinson’s disease, 
amyloid beta plaques in Alzheimer’s disease, and SOD1 in amyotrophic lateral sclerosis. 
However, TIA1 has a direct relationship with inflammatory cytokine tumor necrosis 
factor alpha (TNF-a) and apoptotic factor cyclooxygenase-2 (COX-2). TIA1 acts as a 
translational silencer for both COX-2 and TNF-a, selectively regulating the expression of 
both transcripts (Dixon et al. 2003, Piecyk et al. 2000). Given this relationship, it can be 
inferred that, due to pathologic tau’s effects on TIA1, pathologic tau initiates a 
biochemical cascade of events leading to the dysregulation of both TNF-a and COX-2. 
This change in inflammatory and apoptotic markers then alters normal neuronal function 
and is likely to contribute to neurodegeneration.  
Figure 2. Pathological stress granule development. (Ash et al., 2014) Series of 
molecular and biochemical events that lead to neurodegenerative disease.  
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Microglia 
 There are four functionally distinct types of neuroglia which, combined, serve to 
protect, nourish, and maintain homeostasis within the central nervous system. These 
include oligodendrocytes, astrocytes, ependymal cells and microglia. Oligodendrocytes 
are primarily known for their role in normal and reparative myelination, astrocytes 
provide nutrient and ionic homeostasis to the neuron and function as support for the 
blood brain barrier, ependymal cells aid in the flow of cerebral spinal fluid, and microglia 
function to protect neurons by responding to neuroinflammation, invasion of foreign 
particles, and damage to tissue (Bear et al. 2007). Each neuroglia type is vital for normal 
and continued functioning of the central nervous system and dysfunction of any neuroglia 
can have disastrous effects. However, within the past decade, microglia have garnered 
perhaps the greatest attention in the field of neurodegenerative diseases. Due to 
microglia’s sensitivity to cellular responses commonly associated with neurodegenerative 
disease, recent studies have postulated microglia’s diagnostic capabilities in, and possible 
contributions to, the onset or progression of neurodegenerative diseases (Perry et al. 
2010). 
Microglia are widely known as the microphages of the brain. This vital 
neuroimmune function allows microglia to present in many different ways within the 
brain depending on what is required from surrounding neuropil. Different phenotypes of 
microglia can be categorized based on ramification of their projections and size of their 
soma. In a healthy subject, microglia are characterized by its long ramified projections 
and small round soma (Savage et al. 2018). This phenotype is observed when microglia 
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are performing routine surveying and housekeeping of the surrounding tissue. For many 
years this less active state of microglia has been considered the ‘resting’ phenotype. 
However, investigators in the field suggest microglia should not be considered to be 
resting at any moment, as they are constantly engaged in these homeostatic functions 
(Hickman et al., 2018). When the surrounding tissue experiences any form of injury, 
microglia are first on the scene. In injured or disease states, the microglia phenotype 
transitions into what is considered a more active state. Here, the soma enlarges and 
appears less circular and more amoeboid in shape while microglia’s long ramified 
processes become hyper-ramified (Hinwoord et al. 2011). Depending on the disease state, 
microglia can continue into a reactive form where its hyper-ramified processes shorten 
and can then continue further into a phagocytic phenotype (Figure 3, Hinwood et al. 
2011). In this state, microglia initiate an inflammatory response by releasing 
cytokines and chemokines to recruit the adaptive immune system for help (Hickman et al. 
2018).  Microglial responses in neurodegenerative disease are being heavily investigated. 
Specifically, in AD, microglia respond immediately to Ab plaque formation. Although 
Figure 3. Microglial phenotype in different states of activation (Hinwood, 
2011). This diagram visualizes the changes with microglial processes in response 
to worsening disease states or injuries in the surrounding tissue.  
 
 A - Ramified              B - Hyper-ramified        C - Reactive      D - Phagocytic  
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this initial response has been shown to be helpful in the phagocytosis of Ab, this response 
leads to early synapse loss as well as an increase in tau hyperphosphorylation and 
neurofibrillary tangle formation (Hammond et al., 2018). In tauopathies, once microglia 
enter more active states, they no longer aid in the degradation and clearance of tau. It has 
been shown that hyper-ramified, amoeboid, proinflammatory, reactive microglia 
contribute to the hyperphosphorylation of tau and facilitate the progression of tau 
pathology (Asai et al., 2015). Our lab has demonstrated microglial response to tauopathy 
using the P301S mouse model of AD. In this model, the expression of RNA binding 
protein TIA1 was manipulated to observe changes in microglial density, morphology, and 
proinflammatory marker expression in the dentate gyrus (PhD Candidate Chelsey 
LeBlang). The results of this previous work suggest that decreasing the expression of 
TIA1 in these models produces an increase in microglial density as well as an increase in 
hyper-ramified, reactive, and proinflammatory microglial phenotypes (Figure 4). This 
increase lends support to the hypothesis that TIA1 expression is heavily integrated in 
tauopathy and decreasing its expression results in microglial phenotypes that further 
neuroinflammation and progression of tau pathology. 
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Purpose of this Study  
The purpose of this study is to evaluate how microglial activity changes with the 
manipulation of RNA binding protein TIA1 within the P301S mouse model of tauopathy. 
With four groups of P301S mice (P301S TIA1+/+, P301S TIA1 +/-, P301S TIA1 -/-, wild 
Figure 4. Changes in microglial density in response to TIA1 expression. 
A) Our lab’s previous work showing an increase in microglial density with a 
decrease in TIA1 expression. Specifically observing an increase in 
proinflammatory microglia. B) In comparison to WT, the P301S model 
exhibits a clear dose dependent increase of microglial density in response to 
decreasing TIA1 expression. Data kindly provided by Chelsey LeBlang. 
A 
B 
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type (WT)), the role of TIA1 and the effect of differential TIA1 expression will be 
evaluated. As stated previously, the RNA binding protein TIA1 regulates the expression 
of inflammatory cytokine TNF-a and apoptotic factor COX-2. Furthermore, in studies 
looking at microglia in the P301S mouse model, it has been shown that microglia are 
activated even before neurofibrillary tangle formation (Yoshiyama et al. 2007). It is our 
goal to investigate how microglia change in response to the biochemical processes 
associated with tauopathy and the dysregulation of TIA1. Our previous work has shown 
that, in the dentate gyrus of the P301S mouse model, there is a dose dependent 
relationship of decreasing TIA1 expression with increasing microglial density. These data 
suggest that without proper functioning by TIA1, there is an increase in 
neuroinflammation and an increased density of microglia per volume of tissue. To 
evaluate this relationship further, we performed an ultrastructural analysis using electron 
microscopy. This analysis involved the reconstruction of microglia, and its AT8+ 
(phosphorylated tau) and AT8- (non-phosphorylated tau) appositions, within the hilus 
and granular cell regions of the dentate gyrus in the hippocampus. The appositions 
defined and analyzed in this thesis are: unmyelinated axons, myelinated axons, axonal 
boutons, dendritic spines, dendrites, and somata. This study aims to understand what 
changes occur in microglial activity with the manipulation of TIA1 in a mouse model of 
tauopathy. Understanding this relationship will allow for a more informed understanding 
of the role of microglia in tauopathy and how this can change in response to TIA1 
expression. 
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METHODS  
Experimental subjects  
 In this study the brains of four mice were used to assess the ultrastructural 
features of two regions of the hippocampus- the granular cell layer and the hilus. One 
non-transgenic mouse (wild type, WT) served as the control. The remaining experimental 
mice were transgenic P301S mouse models, each with varying manipulations of the RNA 
binding protein TIA1: TIA1 knock out (TIA1 -/-), heterozygous TIA1 expression (TIA1 
+/-), and full TIA1 expression (TIA1 +/+). Each genotype was confirmed with genotypic 
PCR analysis of the tail of each subject. The age of perfusion of each mouse was 180-200 
days from birth (9-9.5 months old). The handling and care of our mice followed the 
guidelines of the National Institutes of Health Guide for the Care and Use of Laboratory 
Animals. Protocols for the care of our mice were approved by the Institutional Animal 
Care and Use Committee (IACUC) at Boston University. In following these guidelines, 
mice had 24-hour ad libitum access to food and water.  
 
Perfusion and slice preparation 
The weight of each mouse was recorded to appropriately calculate the 
administration of Henry Schein Socumb Solution (6 grains sodium pentobarbital/250mL; 
1:10 dilution in sterile saline). An intraperitoneal injection of 14µL per gram was given to 
anesthetize each mouse for transcardial perfusion. The solution used to perfuse and fix 
the mouse tissue was 50mL of 4% paraformaldehyde. Following perfusion, the head was 
isolated and the calvarium was removed from the skull. The exposed brain then remained 
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in the head for 24 hours in 4% paraformaldehyde at 4°C. After the 24-hour period, the 
brain was removed, weighed, and prepared for slicing. The olfactory bulbs, 1mm of the 
prefrontal cortex, and cerebellum were removed by hand using a sharpened blade and the 
remaining tissue was mounted on a block of agar for sectioning on a vibratome. Gross 
anatomy of the P301S brain did not appear different than wild type. Coronal, 100µm 
slices were cut beginning at the caudal forebrain and continuing to the most rostral point 
of the remaining tissue. Slices were then stored at -20°C in a well plate containing 
antifreeze solution.  
 
Electron microscopy and Immunohistochemistry embedding and staining procedures 
Tissue was prepared for both electron microscopy and immunohistochemistry, 
thus both procedures will be described here. However, only ultrastructural results from 
analyses of the electron micrographs will be discussed in this thesis. The hippocampal 
tissue from all four subjects was used for the following procedures.  
Immunohistochemistry 
 Slices from the whole brain were prepared for blocking using a series of 0.01M 
PBS solution washes, an immersion of 5% bovine serum albumin solution to minimize 
non-specific hydrophobic interactions between antibodies, and three sets of 5-minute 
incubation periods in a microwave to allow our three primary antibodies (1: 40µL of 
.01M mouse-Anti-AT8 from Thermofisher, 2: 40µL of .001M Goat-Anti-IBA1 from 
Thermofisher, 3: 8µL of .02M Rabbit-Anti-TIA1 from Abcam) to penetrate the tissue. 
The secondary antibodies (20 µL of .05M donkey anti-goat FAB biotinylated secondary 
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antibody from Jackson Labs, 40µL of .01M donkey anti-mouse gold secondary antibody 
from Electron Microscopy Sciences) as well as the gold incubation buffer were then 
coincubated and left to set over night. Jackson Labs report that the gold particles used are 
8nm in size pre-silver enhancement. The gold incubation buffer was administered to label 
pathological tau protein within the tissue. After a set of 0.1M PB, sodium citrate, and 
deionized water rinses, a silver enhancement was performed to amplify the size of the 
gold particles. To aid in the labeling of IBA1, the tissue was incubated to create avidin 
biotin complex. This method is commonly used in immunohistochemistry where avidin is 
labeled with a high affinity molecule for biotin, a peroxidase of fluorescein, and biotin is 
then conjugated to the avidin through incubation. This was followed by diaminobenzidine 
(DAB) reaction to label nucleic acids and proteins within the cell. Tetramethylbenzidine 
(TMB) was introduced, incubated and stabilized to aid in the amplification of the 
antibody for TIA1. Tissue was then washed 3x in 0.1M PB followed by a post fixation 
incubation period using a 6% glutaraldehyde 2% paraformaldehyde solution. 
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Tissue Preparation for Electron Microscopy 
The fixed tissue was rinsed three times using 0.1M PB solution and prepared for 
osmication according to previously described methods (Ludvingson et al., 2011). The 
tissue was osmicated using a 1.5% potassium iron and 1% osmium solution in 0.1M 
phosphate buffer. Another series of 0.1M PB rinses were performed. The fixed and 
osmicated tissue was dehydrated using an increasing concentration of ethanol starting at 
50% ethanol and increasing to 100% over time. Dehydration was occurred after two 
100% propylene oxide rinses. Next, using a 1:1 Araldite:Propylene Oxide solution, the 
embedding medium was infiltrated over a two hour immersion period. The tissue was 
stored overnight in a vacuum desiccator in fresh 100% Araldite solution. The 
Figure 5. Electron micrographs. Electron micrograph of P301S TIA1-/- in the hilus 
(left) and granule cell layer (right). Scale bars at bottom left of each image: 1.0µm.  
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hippocampal tissue was placed in pure Araldite the next day and cured for 48-72 hours at 
58-64°C for hardening.  
 
Sectioning and Electron microscopy 
Approximately twenty 50µm sections were cut from 
each block with a diamond knife, and transferred onto 
copper grids in groups of 3-5 sections per grid. Each 
grid was then imaged and analyzed using a JOEL JEM 
1011 transmission electron microscope. Two regions 
of the hilus and one region of the granular cell layer 
was imaged within the hippocampus. In each area of 
interest, anywhere between 1-3 subfields were imaged. 
The magnification of our electron micrographs was 
20,000x with a resolution of 0.0026 pixels.  
 
Data Analyses with Reconstructä 
Photoshop was used to merge the subfields into a single continuous electron 
micrograph. These images were then imported into the Reconstructä software (John. C. 
Fiala) to quantify ultrastructural features of the neuropil. Once imported, the images were 
calibrated for alignment on a 1µm scale. The mitochondria of each electron micrograph 
were used to align the series. Following alignment, microglia were analyzed in 2 and 3 
dimensions. Every microglia within the electron micrograph was reconstructed using an 
Figure 6: Reconstructed 
microglia. Reconstructed 
microglia using section by section 
tracing tool. Scale: 0.5µm3 
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individual tracing tool. After successful reconstruction, all identifiable structures 
contacting the microglia were tagged and reconstructed. These structures include: 
unmyelinated axon, myelinated axon, bouton, spine, dendrite and soma. Quantitative 
analysis comparing was performed based on the parameters exported from Reconstructä. 
This analysis was based on the amount and type of appositions by microglia, the surface 
area of these appositions, and the parameters below. All data represented in figures 
represent the mean and standard error of the sample. A standard error of 0.0 indicates the 
mean is a single value without standard error.  
Table 1. Parameters used for analyses, total and by genotype. 
Using these parameters microglial volume per volume of tissue, microglial appositions 
per volume of tissue, surface area of individual appositions, and fractional apposition 
surface area on total microglial surface area were calculated. In each case, a comparison 
was made using this information between the hilus and granule cell layer as well as tau 
(AT8+) and non-tau (AT8-) containing appositions. 
Number of Microglia Sampled 44 
   
Total Volume of Tissue Sampled   5141.88 
   
 
TIA1+/+ TIA1+/- TIA1-/- WT 
Total Microglial Surface Area 
Per Animal 199.451 138.08 61.285144 75.1344 
Average Microglial Surface Area  18.1319412 6.57532475 7.660643 18.7835 
Volume of Tissue Per Animal  1094.26556 2861.7884 841.71889 334.10668 
Number of Microglia per Animal  11 21 8 4 
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RESULTS 
Qualitative Observations   
Mitochondria Morphology  
 Abnormal mitochondrial phenotypes were frequently observed (Figure 7). Many 
mitochondria appeared to be “shedding” microtubules from their cisternae and releasing 
them into the surrounding tissue. In some mitochondria, a visible hole was formed 
(Figure 7A). Although the hole was only seen in a few mitochondria, microtubule 
shedding was consistent in all phenotypically abnormal mitochondria. We were able to 
reconstruct one shedding mitochondria to visualize its morphology (Figure 7B). This 
phenotype was not observed in the wild type subjects but was consistently observed in 
both the hilus and granule cell layer of all experimental groups (P301S TIA+/+, P301S 
TIA+/-, P301S TIA-/-). Furthermore, many mitochondria exhibited a ballooning within 
their membranes, appearing to be a degeneration of the inner mitochondrial membrane 
(Figure 7C). 
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Figure 7A-C. Abnormal Mitochondrial Phenotypes. A) Electron micrograph of 
mitochondria exhibiting the microtubule shedding effect. This specific 
mitochondria was also exhibiting the hole effect seen in a few others. B) This is a 
3D reconstruction of an abnormal mitochondria. C) A mitochondria demonstrating 
bubbling of the internal mitochondrial membrane (red arrows).  
A B 
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 Microglial Migration  
 It was commonly found that, when a microglial process or soma was contacting a 
defined neural structure, the mitochondria within that structure had migrated toward the 
microglial apposition (Figure 8). As seen below, the mitochondria itself is not touching 
the microglia as it is still contained within the structure. This interaction was frequently 
seen.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8. Intraneuronal Mitochondrial Migration. An electron 
micrograph displaying a mitochondria within a dendrite localized 
closely to the dendrites apposing microglia. Mitochondria of interest 
are indicated in blue (within bouton) and red (within dendrite). 
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Microglial Trogocytosis 
 As described previously, microglia have the ability to phagocytose neural 
structures, specifically presynaptic structures. An example is shown below (Figure 9). 
This phenomenon was observed in both the hilus and granule cell layer of the dentate 
gyrus.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9. Microglial Trogocytosis of Presynaptic Structures.  
As indicated by blue arrows, this microglia (green) is observed 
“taking in” myelinated axons (blue arrows). The black bar seen 
within the microglia is a scale bar (1.0µm). 
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Axonal Demyelination  
 Within the hilus, across all transgenic genotypes, dystrophic myelin was quite 
apparent. It occurred in different degrees, however most axons exhibited some form of 
myelin dystrophy. It presented as a loosening of myelin around the axon as well as a 
uniform blebbing of the myelin (Figure 10).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10. Demyelinating Axons. Three demyelinating axons in cross section.  
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Tau Gold Staining and Filament Presence  
Typically seen most clearly in dendrites, tau filaments in experimental groups 
were observed (Figure 11). During data collection, structures were identified as tau or 
non tau based on the presence of gold or these tau filaments. Tau was also visualized 
using gold staining techniques, which appears as black dots on an electron micrograph. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 11. Tau Filaments and Gold Staining Tau. Gold particles indicated 
with red arrows. This staining was used to identify tau within neuronal 
structures. Tau filaments can be visualized within the green circle.  
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Figure 12. Microglia in Sampled Tissue. This electron micrograph 
allows for visualization of microglial volume in one section of tissue. 
Using tracing techniques in Reconstructä, individual traces surrounding 
the microglia through the entire series are combined and microglial 
volume can be found within an entire sample of tissue. Bottom left scale 
bar: 1.0µm.  
 
Mi
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Quantitative Observations 
Total Microglial Volume in the Dentate Gyrus 
The volume per volume of tissue which microglia occupied was compared 
between genotypes and field of dentate gyrus. Each microglia was reconstructed section 
by section (Figure 12) and the volume of a microglia is given by these reconstructions 
and used to calculate total microglial volume within the given volume of tissue. 
Ultrastructural analyses revealed that fractional microglial volume in the hilus differed in 
the four groups (P301S TIA1 +/+, P301S TIA1+/-, P301S TIA1 -/-, WT) such that both 
WT (0.17µm ± 0.09) and P301S TIA+/+ (0.12µm ± 0.03) microglial volume was greater 
than that of P301S TIA1+/- (0.020µm ± 0.01) and P301S TIA1 -/- (0.03µm ± 0.01), 
respectively (Figure13). Total microglial volume in the GCL did not exhibit significant 
differences (p=0.824), however there was a significant trend in the hilus (p=0.0003). This 
relationship in the hilus was such that WT (TIA +/- HSD p=0.003, TIA-/- HSD p=0.006) 
was significantly greater than TIA+/- and TIA-/- as was TIA+/+ (TIA+/- HSD p=0.07, 
TIA-/- HSD p=0.024) respectively. This showed a specific effect of TIA1 manipulation 
on microglial volume in the hilus that is not observed in the GCL.  
Density of Neural Structures Contacted by Microglia per Tissue Volume 
Density of AT8+ and AT8- structures apposed per tissue volume (# of 
structures/µm3 tissue) was quantified in the hilus and GCL. This was done generally with 
presynaptic and postsynaptic structures (Figure 14A,B) and then separated by defined 
structures (Figure 14C,D). Statistical analyses did not reveal differences when 
comparisons were made between genotypes in the hilus or between AT8 groups in the 
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hilus. However, there were statistically significant differences across genotypes and 
between AT8 groups in the GCL. The density of AT8- presynaptic appositions by 
microglia was significantly greater (p=0.045) than AT8+ presynaptic appositions across 
genotypes. In the GCL of P301S TIA-/-, there was a greater density of AT8- presynaptic 
(0.127 #/µm3 ± 0.0) and postsynaptic (0.0127 #/µm3 ± 0.0) appositions when compared to 
P301S TIA1 +/- (0.04 #/µm3 ± 0.01) and P301S TIA+/+ (0.05 #/µm3 ± 0.02) (Figure 
14A). This finding was not seen in the hilus, nor were other significant results with 
regard to density of pre and post synaptic microglial contacts per tissue volume (Figure 
14B). When separated into defined structures in the GCL, it was found that AT8- 
dendritic spines (0.10 #/µm3 ± 0.0) and axonal boutons (0.10 #/µm3 ± 0.0) in the P301S 
TIA-/- were significantly greater than AT8- structures in TIA+/- and TIA +/+ (spines, 
p=0.033; boutons, p=0.044) (Figure 14C). Furthermore, the density of AT8+ dendrites 
apposed per tissue volume in the GCL of P301S TIA-/- (0.80 #/µm3 ± 0.0)  approached 
significance as higher than AT8+ dendrites in all other genotypes (p=0.066). In the hilus, 
there were no notable trends to report regarding the density of microglial appositions per 
tissue volume (Figure 14D). From this data it seems that there was no effect of apposition 
density in the hilus, however, in the GCL density of appositions on pre and post synaptic 
structures was greater in P301S TIA-/- than in P301S TIA+/- and P301S TIA+/+. 
Furthermore, microglia seem to target AT8- presynaptic structures across all genotypes. 
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Number of Neural Structures Contacted by Microglia in the Dentate Gyrus  
The number of AT8+ and AT8- structures apposed per microglial surface area (# 
of structures/µm2 microglia) was quantified in the hilus and GCL. This was done 
generally with presynaptic and postsynaptic structures (Figure 15A,B). This 
quantification was then separated by defined structures (Figure 15C,D) and can be seen in 
Figure 16, where appositions are represented in circles upon a reconstructed microglia. 
Statistical analyses did not confer significance when comparisons were made between 
genotypes in the GCL or hilus as well as between AT8 groups in the hilus. However, in 
the P301S GCL, the amount of AT8- presynaptic structures apposed by microglial 
surface area were significantly greater than AT8+ presynaptic structures (p=0.003). A 
similar trend was seen when comparing AT8+ to AT8- postsynaptic structures, but this 
relationship was not significant. Furthermore, in the GCL of P301S TIA+/-, there was a 
marked increase in the number of post synaptic AT8+ appositions (1.46 #/µm2 ± 0.44) on 
microglial surface area when compared to other genotypes and when compared to AT8- 
presynaptic structures in P301S TIA+/- (0.90 #/µm2 ± 0.22) (Figure 15A). In the hilus, 
there was a dose dependent trend where, with decreasing TIA1 expression, there was an 
increase in the number of AT8- presynaptic appositions per microglial surface area 
(Figure 15B). A trend that was weaker, but still seen with AT8+ and AT8- post synaptic 
structures in the hilus. When separated into defined structures, the GCL did not exhibit 
significant comparisons or trends (Figure 15C). It was found that, within the hilus, the 
amount of AT8- boutons and spines apposed by microglia in the P301S TIA-/- and P301S 
TIA+/- was greater than AT8- boutons and spines in P301S TIA+/+ (Figure 15D). 
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However, the number of AT8+ boutons and spines per microglial surface area was 
greater in the P301S TIA-/- when compared to both P301S TIA+/- and P301S TIA+/+.  
From this data we found an interesting relationship in the hilus where the number of 
AT8- presynaptic appositions on microglia increases with decreasing expression of TIA1. 
Furthermore, any decrease in TIA1 expression increased the number of both AT8- spine 
and bouton appositions per microglial surface area.  Full knockout of TIA1 expression 
increased the number of AT8+ spine and bouton apposition per microglial surface area.  
 
Surface Area of Microglia-Neuron Contacts  
 The surface area of individual microglial appositions on neuronal structures 
within the GCL and hilus neuropil were compared across genotypes (Figure 17A-H) and 
in total across genotype (Figure 18). Surface area per apposition can be visualized with 
the 3D reconstruction found in Figure 19. When considering average surface area 
between AT8+ and AT8- structures and genotypes, AT8+ somata in the P301S TIA+/+ 
(4.58µm ± 1.15) and WT (3.30µm ± 1.09) hippocampal tissue were apposed by larger 
microglial appositions than AT8+ somata in the P301S TIA+/- (1.09µm ± 0.53) and 
P301S TIA -/- (0.14µm ± 0) (Figure17E). It is notable that microglia do not contact AT8- 
somata, with the exception of a single somatic contact by microglia in P301S TIA+/-. 
Furthermore, microglial appositions on AT8+ myelinated axons in the P301S TIA-/- 
(0.76µm ± 0.08) were larger in surface area compared to those in other genotypes [P301S 
TIA+/+ (0.15µm ± 0.1), P301S TIA+/- (0.37µm ± 0.10), and WT (0.00µm ± 0.0)] 
(Figure18). Analyzing surface area allowed us to find that AT8+ soma interacted much 
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more with microglia than AT8- somata and this can be seen in both the hilus and granule 
cell layer in each phenotype.  
 
Fractional Surface Area of Microglia Apposed to Neuronal Structures  
 The surface area of each apposition by microglia, on average, occupies a certain 
percent of total microglial surface area, which can also reflect the extent of microglial-
neuron interactions. In all of the genotypes, about 67.56% of the microglial surface area 
was apposed with defined AT8+ and AT8- neuronal structures in the GCL and hilus 
(Figure 19). This relationship is demonstrated in the bar graphs of Figure 20 and 21. 
Statistical analyses did not confer significance when comparisons were made between 
genotypes in the GCL or hilus as well as between AT8 groups in the hilus. However, 
when comparisons were made between fractional surface area in AT8+ and AT8- 
structures in the GCL, a significant difference was found in axonal boutons (p=0.005) 
and near significance was reached in dendrites (p=0.052) (Figure 21A). This relationship 
was such that fractional surface area of AT8- boutons were significantly greater than 
AT8+ boutons, and AT8+ dendrites were greater than AT8- dendrites. Furthermore, 
when comparing fractional surface area of AT8- presynaptic structures to their AT8+ 
counterparts, it was found that AT8- structures significantly differ from AT8+ structures 
(p=0.048). This same pattern of significance was found in postsynaptic structures of the 
GCL (p=0.031) where AT8+ postsynaptic structures were significantly greater than AT8- 
postsynaptic structures (Figure 20A). In the GCL, the fractional surface area of AT8- 
presynaptic structures [P301S TIA+/+ (0.17 ± 0.13), P301S TIA+/- (0.15 ± 0.05) and 
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P301S TIA-/- (0.15 ± 0.0)] was greater than AT8- postsynaptic structures in all P301S 
mice [P301S TIA+/+ (0.01 ± 0.01), P301S TIA+/- (0.12 ± 0.03) and P301S TIA-/- (0.11 
± 0.0)]. A trend can be seen where the fraction of AT8+ postsynaptic appositions by 
microglial surface area in the GCL, increases with decreasing TIA1 expression. A notable 
finding in the hilus of P301S TIA+/- was a larger fractional surface area of microglia 
apposing AT8+ postsynaptic structures (0.39 ± 0.10), when compared to presynaptic 
structures (0.05 ± 0.02) (Figure 20B). Furthermore, we found that the fractional surface 
area of microglia on presynaptic AT8- structures in the hilus exhibit a dose dependent 
increase with decreasing TIA1 expression. A similar but weaker relationship was seen 
with AT8- postsynaptic structures. When separated into defined structures in the GCL, 
fractional surface area of AT8+ dendritic structures apposed by microglia were greater in 
P301S TIA-/- (0.46 ± 0.0) and P301S TIA+/- (0.36 ± 0.18) than in P301S TIA+/+ (0.06 ± 
0.06) and WT (0.20 ± 0.0) (Figure 21A). Within the P301S animals, there was a dose 
dependent increase in fractional surface area of dendrites apposed by microglia with 
decreasing TIA1 expression. Furthermore, the fractional surface area of AT8- boutons 
apposed by microglia was greater than all other structures in the GCL of P301S TIA-/-, 
P301S TIA+/-and P301S TIA+/+. In the hilus, it was found that the fractional surface 
area of AT8+ dendrites in P301S TIA+/- (0.37 ± 0.10) was greater than all other AT8+ 
and AT8- structures within P301S TIA+/- (Figure 21B). A notable trend was observed in 
AT8- boutons, where an increase in fractional surface area was seen with decreasing 
TIA1 expression. Otherwise, there were no other notable comparisons between AT8- and 
AT8+ structures or between genotypes. Our data here suggests that AT8- presynaptic 
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structures have a larger fractional surface area when compared to AT8- postsynaptic 
structures in the GCL. Furthermore, when considering AT8+ structures in the GCL we 
found the opposite. That fractional surface area was larger with AT8+ postsynaptic 
structures when compared to AT8+ presynaptic structures. These trends were not seen in 
the hilus. However, there was an increase in fractional surface area of both presynaptic 
and postsynaptic AT8- structures with decreasing TIA1 expression.  
 
Fractional Microglial Volume  
 Genotype 
Genotype 
Comparison 
ANOVA p 
value 
Tukey HSD 
(sig) 
Bonferri 
(sig) 
Hilus 
WT TIA-/- 
0.000308 
0.006 0.007 
 TIA+/- 0.003 0.0030 
 TIA+/+ 0.553 1 
Density of Appositions per Tissue Volume 
 Comparison Structure Statistic 
Significance 
(p)  
GC 
AT8 Presynaptic ANOVA 0.045  
AT8 Spines ANOVA 0.033  
AT8 Boutons ANOVA 0.044  
TIA1 My. Axons ANOVA 0.027  
Number of Appositions per Microglial Surface Area 
 Comparison Structure Statistic 
Significance 
(p)  
GC AT8 Bouton ANOVA 0.003  AT8 Presynaptic ANOVA 0.003  
Fractional Surface Area of Appositions on Microglial Surface Area 
 Comparison Structure Statistic 
Significance 
(p)  
GC 
AT8 Bouton ANOVA 0.005  
AT8 Presynaptic ANOVA 0.048  
AT8 Postsynaptic ANOVA 0.031  
Table 2. Significant Results Reported by Each Analysis. Statistically significant results 
for each measure are shown. 
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TIA-/- TIA+/- TIA+/+ WT TIA-/- TIA+/- TIA+/+ WTGC Hilus
Fractional	Microglial	Volume	per	Volume	of	Tissue
Figure 13.  Fractional Volume of Microglia per Volume of Tissue by 
Genotype. Bar graph of microglial volume per volume of sampled tissue (µm3 
microglia/µm3 tissue) by genotype and separate by field within the dentate gyrus.  
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Figure 14A-B.  Density of Total Presynaptic and Postsynaptic Microglial 
Contacts per Tissue Volume in the Hilus and GCL. Bar graph representing the 
density of microglial contacts (# of appositions/µm3  of tissue) on AT8+/- 
presynaptic and postsynaptic structures with the GCL (A) and the hilus (B) of all 
four genotypes.  
A 
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Figure 14C-D.  Density of Defined MG-Neuron Contacts per Tissue Volume in 
the GCL and Hilus. Bar graph representing the density of microglial contacts (# of 
appositions/µm3  of tissue) on all defined structures, identified in the legend, with 
the GCL (A) and the hilus (B). Structures were separated based on presence of tau 
(AT8+ or AT8-) and have been separated by genotype.  
C 
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Figure 15A-B.  Number of Total Presynaptic and Postsynaptic Appositions on 
Microglial Surface Area in the GCL and Hilus. Bar graph representing the number 
of AT8+/- presynaptic and postsynaptic appositions per microglial surface area (# of 
contacts/µm2  of microglia) in the hilus and GCL across all four genotypes.  
A 
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Figure 15C-D.  Number of Defined Neuronal Structure Appositions on Microglial 
Surface Area in the GCL and Hilus. Bar graph representing the number of AT8+/- 
defined neuronal appositions per microglial surface area (# of contacts/µm2  of 
microglia) in the hilus and GCL across all four genotypes.  
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Figure 16.  Microglial Reconstruction with Appositions. 3D 
Reconstruction of microglia with contacts indicated with colored 
circles. Scale: 0.5µm 
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Figure 17A-H. Microglial Apposition Surface Area by Genotype and Field of 
Hippocampus. Box and whisker plot representing surface area of the all AT8+ (blue) and 
AT8- (green) appositions in P301S mice across genotypes: TIA+/- (A,B) TIA-/- (C,D) 
TIA+/+ (E, F) and WT (G,H). (M. Axon=Myelinated Axon) 
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Figure 19. Microglial Reconstruction with Appositions Traced. A 3D 
reconstruction of a microglial soma. In this section we can visual unmyelinated 
axons (red), dendrite (yellow), and spines (pink). Scale bar: 0.5µm.  
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Figure 20A-B.  Fractional Area of Total Presynaptic and Postsynaptic 
Appositions on Microglia in the GCL and Hilus. Bar graph representing the fraction 
of microglial surface area apposed by the surface area of AT8+/- presynaptic and 
postsynaptic structures within the GCL (A) and Hilus (B).  
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Figure 21A-B. Fractional Surface Area of Defined Neuronal Structures on 
Microglia in the GCL and Hilus. Bar graph representing the fraction of microglial 
surface area apposed by the surface area of AT8+/- defined neuronal structures within 
the GCL (A) and Hilus (B).  
 
 
00.1
0.20.3
0.40.5
0.6
	AT8- AT8+ AT8- AT8+ AT8- AT8+ AT8- AT8+TIA-/- TIA+/- TIA+/+ WT
Fractional	SA	of	Defined	Structures	on	Microglia	in	the	GCL Axon My.	AxonBouton SpineDendrite
0
0.1
0.2
0.3
0.4
0.5
0.6
AT8- AT8+ AT8- AT8+ AT8- AT8+ AT8- AT8+TIA-/- TIA+/- TIA+/+ WT
Fractional	SA	of	Defined	Structures	on	Microglia	in	the	HilusAxon My.	AxonBouton SpineDendrite
A 
B 
	 43	
DISCUSSION 
 Being critical immunological cellular constituents of the brain, microglia serve to 
protect neural tissue and maintain homeostasis. Changes in the morphology and location 
of microglia as neural tissue undergoes degeneration could be an important indication for 
which immunological and biochemical mechanisms are occurring during disease states. 
By defining how microglia change in response to TIA1 manipulation in the hilus and 
granule cell layer of the dentate gyrus, we assessed whether these changes in morphology 
of microglia support the changes previously seen (PhD candidate Chelsey LeBlang) by 
this manipulation in the dentate gyrus. Using immunohistochemistry, our lab has 
previously suggested that microglia within the dentate gyrus exhibit significant changes 
in response to TIA1 manipulation in the P301S mouse model of AD (PhD candidate 
Chelsey LeBlang). This relationship is such that microglial density significantly differs 
between WT, P301S TIA1+/+, P301S TIA1+/-, and P301S TIA1-/-; following a 
correlation where density increases in a dose dependent manner as TIA1 expression 
decreases.   
The purpose of this study was to provide a better understanding of how microglia 
change in response to TIA1 manipulation on an ultrastructural level. We assessed how 
structures are interacting with microglia, if there is a difference in this interaction based 
on the presence or absence of tau within these structures, and compared these interactions 
in the hilus and granule cell layer of the dentate gyrus within the hippocampus. 
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Microglial Volume Decreases with Decreasing TIA1 Expression 
 As microglia were first being studied in models of Alzheimer’s disease (AD), it 
was suggested that microglia, in their activated state, were neurotoxin producing immune 
effector cells directly involved in the neurodegeneration seen in AD (Streit, 2004). This 
was referred to as the “microglial dysfunction hypothesis.” Although it is seemingly 
counterintuitive to its innate function as a neuroimmune cell, this hypothesis continues to 
prevail today. In 2018, Hickman et al. suggests a double edge sword theory of microglia 
in tauopathy. Microglia indeed are helpful in the targeting and clearing of tau, at first. 
However, this attempt to aid neuronal structures does not protect against tau toxicity due 
to dysregulation of microglial function with the progression of tauopathy (Bhaskar et al., 
2010). Microglial volume is strongly implicated in tau pathology and has been shown to 
increase with elevated tau pathology (Sayed et al., 2018). In our study, microglial volume 
per volume of tissue was significantly higher in the hilus of the normal P301S mouse 
fully expressing TIA1 (P301S TIA+/+) and the control (WT) compared to the TIA1 
knock out (P301S TIA-/-) and TIA1 heterozygous (P301S TIA+/-) groups (Figure 13). A 
similar, but weaker relationship was seen in the GCL. Therefore, assuming that 
increasing microglial volume could be an indication of dysregulated function of 
microglia, our results suggest that decreasing TIA1’s expression serves to protect against 
microglial dysregulation. On the other hand, this relationship could also attributed to 
shortening of microglia’s hyper ramified processes as it transitions into its reactive or 
phagocytic phases, which is seen in disease states and therefore explains a decrease in 
microglial volume.  Finally, it is important to note the difference in the approach of the 
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present study that sampled very small volumes of neuropil containing at most one 
microglial cell, compared to our previous light microscopic assessment of microglia in 
entire fields of the dentate gyrus. 
 
Density of Appositions per Tissue Volume Varies across Genotypes 
Comparisons were made to understand, within the sampled tissue, what the 
density of the appositions by microglia were on presynaptic and postsynaptic structures 
(Figures 14A,B). This comparison was also made with unmyelinated axons, myelinated 
axons, axonal boutons, dendrites, dendritic spines and somata (Figure 14C,D). This was 
done to understand what microglia target most frequently and if this frequency changes 
between AT8+ and AT8- structures as well as between the hilus and granule cell layer of 
the dentate gyrus in the hippocampus. In the GCL, the density of AT8- pre and post 
synaptic structures in P301S TIA-/- is much greater than AT8- pre and post synaptic 
structures in the other P301S genotypes. Furthermore, AT8+ postsynaptic structures had 
a greater density than its AT8+ presynaptic counterparts. When quantifying which 
structures were contributing to this high density, we found that AT8- boutons and spines 
were the greatest contributors. This could be attributed solely on size and frequency of 
the structures within the tissue and this result is not indicative of how much individual 
structures are directly interacting with microglia. However, it is interesting to see that, 
overall, spines and boutons seem to have the highest density of contacts per volume of 
tissue. In 2018, Weinhard et al. observed direct microglial appositions on presynaptic 
structures and spines within the developing hippocampus and has defined potential 
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mechanisms for what could be occurring in our groups. Trogocytosis, as it pertains to 
microglia, is the rapid but partial engulfment of a neuronal structure that is non-apoptotic 
in nature (Weinhard et al, 2018). Presynaptic elements in the developing hippocampus 
are at risk for trogocytosis as a mechanism in postnatal synaptic pruning and circuit 
formation. Our qualitative analysis provides visual support of microglial engulfment of 
postsynaptic structures, and therefore trogocytotic mechanisms in the P301S mouse 
model (Figure 9). Weinhard et al., suggests that microglia target spines to aid in the 
remodeling of post synaptic sites, a postnatal microglial mechanism. The combination of 
presynaptic trogocytosis and postsynaptic remodeling could have important implications 
in our work and how it relates to the microglial “aberrant reactivation” hypothesis 
(Hammond et. al 2018). Due to the fact that these spines and boutons are AT8-, this could 
indicate a protective mechanism of microglia to prevent tauopathy by reverting to 
postnatal mechanisms. This hypothesis is evaluated in depth later on when we consider 
the fractional surface area of microglial appositions. 
 
Number of Appositions per Microglial Surface Area Exhibits Dose Dependent 
Relationship in Hilus 
 
In order to understand how many structures are being directly contacted by 
microglia in respect to microglia’s total surface area, comparisons were made between 
genotype, AT8+/-, and field of dentate gyrus. When considering number of presynaptic 
structures against postsynaptic structures, most comparisons were not significant. 
However, in the P301S TIA+/- group the number of appositions on microglial surface 
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area of AT8+ postsynaptic structures in both the GCL (Figure 15A) and hilus was 
significantly greater than AT8+ presynaptic structures. In the hilus, there is an increase in 
the number of AT8- presynaptic appositions by microglia with decreasing TIA1 
expression (Figure 15B). A similar, but weaker, increase is seen in AT8+ postsynaptic 
structures with decreasing TIA1 expression. This relationship was further analyzed by 
comparing defined neuronal structures. Across all genotypes in the GCL, the amount of 
appositions on AT8- boutons by microglial surface area was greater than AT8+ boutons 
(Figure 15C). Although a similar relationship was not seen in the hilus, it was found that 
any decrease in TIA1 expression resulted in an increase of AT8- spine and bouton 
appositions per microglial surface area (Figure 15D). Overall, these findings lend further 
support to a possible protective or proactive mechanism where microglia are seeking 
AT8- spines and boutons due to increasing dysregulation of stress granules.   
 
Appositional Surface Area by Microglia Increases Dramatically on AT8+ Somata but 
Remains Similar Across Genotypes for Other Structures 
 The surface area of microglial appositions on neuronal structures was plotted and 
categorized by individual structure. Furthermore, surface area of appositions was 
separated by genotype and by field within the dentate gyrus (Figure 17A-H). In the case 
where microglia within a field did not contact a certain structure, it can be seen by lack of 
data points in the box and whisker plots of Figure 17. The surface area of appositions on 
microglial surface area can be visualized in Figure 19, where the colored traces represent 
surface area of apposed structures. Within most genotypes and fields, there were no 
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significant differences between surface area of microglial appositions. However, in the 
granule cell layer of the P301S TIA1+/+, AT8+ somata showed a greater appositional 
surface area than all other structures within the granule cell layer of this group (Figure 
17E). This trend extends into comparisons between average surface area of microglial 
appositions between genotypes (Figure 18). Here we see a notably greater amount of 
microglial surface area dedicated to apposing AT8+ somata in P301S TIA1+/+ and WT. 
With the exception of one AT8- somata (surface area: 0.815µm2), there were no other 
AT8- somata apposed by microglia. This preferential targeting to AT8+ neuronal cell 
bodies supports recent findings where microglia protect somatic structures specifically 
against inhibitory inputs (Chen et al., 2014). This study focused on microglia apposing 
soma in layers III-V of mouse motor cortex. However, the targeting of microglia on 
AT8+ soma, and not AT8- soma, provides compelling support for significant microglial 
interaction at a dysfunctional soma. Whether this interaction is protective or otherwise 
cannot be determined by our analysis. However, Chen et al., provides compelling 
evidence that, in their sample, this is a protective mechanism. They were able to 
demonstrate that somatic invasion by microglia serves to increase neuronal synchronicity 
and that removing microglia eliminates neuroprotection (Chen et al., 2014). Therefore, 
our findings could suggest that microglia are preferentially targeting AT8+ somata as a 
protective mechanism against inhibitory input to increase neuronal synchronicity 
amongst neurons within the dentate gyrus.  
 Furthermore, the surface area of microglia apposed by AT8+ somata in P301S 
TIA1+/+ was greater than that of P301S TIA1+/- of which was greater than P301S TIA1-
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/-. This shows a correlation where, with the decreased expression of TIA1, there is a 
decreased appositional surface area of AT8+ somatic structures by microglia. Using the 
somatic neuroprotection hypothesis, these data could indicate that AT8+ somata exhibit a 
decreased need for neuroprotection with decreasing TIA1 expression. Due to an increased 
stress granule dysregulation with decreasing TIA1 expression, it is possible that there is a 
greater global need for microglia effectively recruiting microglia to other structures. 
Another explanation could be that there is an increase in microglial dysfunction with 
decreasing TIA1 expression, and this could prevent microglia from performing its 
somatic neuroprotective function.  
 
Differences in the Fractional Surface Area of Appositions by Microglia across Fields 
and Genotypes  
 
Each microglia contained a certain percent surface area of structures apposing it. 
On average, 67.56% of the microglia was apposed by defined structures of the neuropil in 
the dentate gyrus. This total percent of surface area was compared between AT8+ and 
AT8- structures across genotypes and between fields. It was found that the fractional 
surface area of AT8+ postsynaptic structures was greater than that of AT8+ presynaptic 
structures in the GCL of each genotype. A similar relationship was found in the hilus in 
most genotypes, however, there was no difference between AT8+ presynaptic and 
postsynaptic structures in P301S TIA-/- hilus. The opposite relationship was seen in the 
GCL where the fractional surface area of AT8- presynaptic structures was greater than 
AT8- postsynaptic structures. The reason for this increased interaction of microglia on 
	 50	
AT8- presynaptic structures and AT8+ postsynaptic structures in the GCL can be 
hypothesized using Beth Steven’s “aberrant reactivity” hypothesis (Hammond et al. 
2018). As mentioned previously, the mechanism of microglial postnatal trogocytosis has 
become of specific interest in the developing hippocampus and has been applied to 
microglia in the neurodegenerating brain. Weinhard et al. explains that microglia take 
part in the remodeling of postsynaptic structures and trogocytosis of presynaptic 
structures postnatally. It has been recently suggested that, the dysregulation of microglial 
signaling pathways we commonly see in early stages of AD, could involve an aberrant 
reactivation of postnatal mechanisms (Hammond et al., 2018). Due to the greater 
fractional surface area of appositions on AT8- presynaptic structures in the GCL and 
AT8+ post synaptic structures by microglia, the “aberrant reactivation” hypothesis could 
be a potential mechanism for why this is occurring.  
After analyzing fractional surface area of defined structures, the most notable 
trend was a dose dependent increase in AT8+ dendritic fractional surface area with 
decreasing TIA1 expression in the GCL (Figure 21A). In the hilus, a similar dose 
dependent increase is seen in AT8- boutons with decreasing TIA1 expression. This 
increase in AT8+ dendrites and AT8- boutons supports the trends seen in AT8+ 
postsynaptic structure fractional surface area and AT8- presynaptic fractional surface 
area.  
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Overall Implications of Microglia in Response to TIA1 Manipulation in the Hilus and 
Granule Cell Layer exhibiting Tau Pathology 
 
Our lab previously found that, with a decrease in TIA1 expression in the P301S 
mouse model, there is an increase in microglial density (PhD Candidate Chelsey 
LeBlang). The findings of this previous study are not consistent with the findings of this 
study, showing an opposite trend albeit using assessment of single microglia in the 
neuropil at the electron microscopic level. Microglial volume per volume of tissue 
decreased with the decreased expression of RNA binding protein TIA1.  
Although fractional microglial volume per volume of tissue exhibited a decrease 
in response to decreasing TIA1 expression, the opposite trend was seen in many 
comparisons. The following variables increased with decreasing TIA1 expression: the 
number of AT8- presynaptic structures per microglial surface in the hilus, the fractional 
surface area of microglia on AT8- presynaptic structures in the hilus, the number of 
AT8+ postsynaptic structures per microglial surface area in the hilus, and the fractional 
surface area of microglia on AT8+ postsynaptic structures in the hilus. Due to decreasing 
microglial volume with decreasing TIA1 expression, these trends could indicate 
specificity for AT8- presynaptic structures and AT8+ postsynaptic structures. Note that 
this trend was not found in the GCL.  
In conclusion, our findings lend support to the aberrant reactivation hypothesis 
during neurodegenerative states and neuroprotective preferential targeting of somatic 
structures. These data contribute to our understanding of how microglia respond to the 
manipulation of RNA binding protein TIA1 and, specifically, to which structures this 
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response effects. In future studies, using immunohistochemistry to categorize types of 
microglial ramification as well as volume of microglial soma will be helpful in 
understanding what an increase or decrease in microglia density means for structures 
within the tissue. In addition to categorizing density, it would be helpful to understand 
what other structures are apposing microglia that are not neuronal in nature (i.e., 
astrocytes) while increasing the depth of the series to capture the entirety of a microglia. 
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